Although no differences were found in the levels of this metabolite in the feces of obese and normal-weight asthmatic patients, our data indicate that, in asthma patients, they are directly correlated with the expression of inflammatory markers (Cxcl10, Nt5e, Cldn4 and Cldn5). The gene discussed is CLDN5; the disease is asthma.